Cd47 Discovery: Flipping The Script On Cancer | Stanford Cancer Institute

CD47 Discovery: Flipping the Script on Cancer | Stanford Cancer Institute

Stanford Cancer Institute

CD47 Antibody treatment shrinks or eliminates human cancer tumors in mice

institutesofmedicine

How to flip the script on cancer #shorts #tedx

The importance of CD47 as a target in MDS and AML

VJHemOnc – Video Journal of Hematology & HemOnc

SIRPα/CD47: Don’t Eat Me!

Promega Corporation

CD47-targeting antibody: targeting the source of non-Hodgkin lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

CD47 antibodies for the treatment of AML and MDS: where is the field moving?

VJHemOnc – Video Journal of Hematology & HemOnc

Women, Living with Cancer | Stanford Cancer Institute

Stanford Cancer Institute

Stanford Women’s Cancer Center: Discovery and Hope

Stanford Medicine

Tackling CD47-positive malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

Barriers to Treatment: Developing CD47 Antibody Therapy for Children's Cancer

Uniquely Stanford | Stanford Cancer Institute

Stanford Cancer Institute

Fueling Discovery

Cancer Research Institute

Centre for Discovery in Cancer Research (CDCR)

Centre for Discovery in Cancer Research

Cancer Vaccine Research: T-Cells Killing Cancer | Stanford Cancer Institute

Stanford Cancer Institute

Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MD

Stanford Cancer Institute

Anti-CD47 antibodies for complex karyotype AML

VJHemOnc – Video Journal of Hematology & HemOnc

CD47-blocking checkpoint inhibitor TTI-621 shows promising results for cutaneous T-cell lymphomas

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Daver on Updated Findings With Magrolimab/Azacitidine in MDS